Protalix BioTherapeutics Names Gilad Mamlok CFO
21/7 13:32
(RTTNews) - Protalix BioTherapeutics, Inc. (PLX), Monday announced the appointment of Gilad Mamlok as new Senior Vice President and Chief Financial Officer, effective August 24, 2025, succeeding Eyal Rubin....